Incyte (INCY) Share-based Compensation Growth (3y) (2013 - 2026)
Incyte (INCY) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | -49.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.30% |
| Sep 30, 2025 | -326.06% |
| Jun 30, 2025 | 11.59% |
| Mar 31, 2025 | 204.45% |
| Dec 31, 2024 | 169.70% |
| Sep 30, 2024 | -67.14% |
| Jun 30, 2024 | 35.01% |
| Mar 31, 2024 | -32.45% |
| Dec 31, 2023 | 30.29% |
| Jun 30, 2023 | -44.85% |
| Mar 31, 2023 | 53.99% |
| Dec 31, 2022 | 485.41% |
| Sep 30, 2022 | -66.55% |
| Jun 30, 2022 | 4.63% |
| Mar 31, 2022 | -48.13% |
| Dec 31, 2021 | -33.90% |
| Sep 30, 2021 | -16.37% |
| Jun 30, 2021 | 42.51% |
| Mar 31, 2021 | 98.11% |
| Dec 31, 2020 | -73.80% |